TP53 and familial pancreatic carcinoma: King et al. [135] reported that, in human pancreatic cancer cells (BxPC-3 and MIA PaCa-2), the p53 DNA binding-specific inhibitor pipitrin-α blocked transcription-dependent p53 activation and, thus, apigenin’s anti-proliferative and pro-apoptotic effects.